Unknown

Dataset Information

0

The glycoimmune checkpoint receptor Siglec-7 interacts with T-cell ligands and regulates T-cell activation.


ABSTRACT: Siglec-7 (sialic acid-binding immunoglobulin-like lectin 7) is a glycan-binding immune receptor that is emerging as a significant target of interest for cancer immunotherapy. The physiological ligands that bind Siglec-7, however, remain incompletely defined. In this study, we characterized the expression of Siglec-7 ligands on peripheral immune cell subsets and assessed whether Siglec-7 functionally regulates interactions between immune cells. We found that disialyl core 1 O-glycans are the major immune ligands for Siglec-7 and that these ligands are particularly highly expressed on naïve T-cells. Densely glycosylated sialomucins are the primary carriers of these glycans, in particular a glycoform of the cell-surface marker CD43. Biosynthesis of Siglec-7-binding glycans is dynamically controlled on different immune cell subsets through a genetic circuit involving the glycosyltransferase GCNT1. Siglec-7 blockade was found to increase activation of both primary T-cells and antigen-presenting dendritic cells in vitro, indicating that Siglec-7 binds T-cell glycans to regulate intraimmune signaling. Finally, we present evidence that Siglec-7 directly activates signaling pathways in T-cells, suggesting a new biological function for this receptor. These studies conclusively demonstrate the existence of a novel Siglec-7-mediated signaling axis that physiologically regulates T-cell activity. Going forward, our findings have significant implications for the design and implementation of therapies targeting immunoregulatory Siglec receptors.

SUBMITTER: Stewart N 

PROVIDER: S-EPMC10831161 | biostudies-literature | 2023 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

The glycoimmune checkpoint receptor Siglec-7 interacts with T-cell ligands and regulates T-cell activation.

Stewart Natalie N   Daly John J   Drummond-Guy Olivia O   Krishnamoorthy Vignesh V   Stark Jessica C JC   Riley Nicholas M NM   Williams Karla C KC   Bertozzi Carolyn R CR   Wisnovsky Simon S  

The Journal of biological chemistry 20231221 2


Siglec-7 (sialic acid-binding immunoglobulin-like lectin 7) is a glycan-binding immune receptor that is emerging as a significant target of interest for cancer immunotherapy. The physiological ligands that bind Siglec-7, however, remain incompletely defined. In this study, we characterized the expression of Siglec-7 ligands on peripheral immune cell subsets and assessed whether Siglec-7 functionally regulates interactions between immune cells. We found that disialyl core 1 O-glycans are the majo  ...[more]

Similar Datasets

| S-EPMC10089186 | biostudies-literature
| S-EPMC8161119 | biostudies-literature
| S-EPMC11794148 | biostudies-literature
| S-EPMC8837033 | biostudies-literature
| S-EPMC6933835 | biostudies-literature
| S-EPMC10229725 | biostudies-literature
| S-EPMC8159688 | biostudies-literature
| S-EPMC4170573 | biostudies-literature
| S-EPMC3685284 | biostudies-literature
| S-EPMC2659237 | biostudies-literature